GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (XAMS:PHARM) » Definitions » Cyclically Adjusted Book per Share

Pharming Group (XAMS:PHARM) Cyclically Adjusted Book per Share : €0.17 (As of Mar. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Pharming Group Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Pharming Group's adjusted book value per share for the three months ended in Mar. 2024 was €0.281. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.17 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Pharming Group's average Cyclically Adjusted Book Growth Rate was 21.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 38.70% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Pharming Group was 38.70% per year. The lowest was -52.20% per year. And the median was 1.45% per year.

As of today (2024-05-24), Pharming Group's current stock price is €0.8265. Pharming Group's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €0.17. Pharming Group's Cyclically Adjusted PB Ratio of today is 4.86.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pharming Group was 21.20. The lowest was 2.13. And the median was 8.64.


Pharming Group Cyclically Adjusted Book per Share Historical Data

The historical data trend for Pharming Group's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharming Group Cyclically Adjusted Book per Share Chart

Pharming Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.06 0.08 0.13 0.16

Pharming Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.15 0.15 0.16 0.17

Competitive Comparison of Pharming Group's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Pharming Group's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharming Group's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharming Group's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pharming Group's Cyclically Adjusted PB Ratio falls into.



Pharming Group Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pharming Group's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.281/128.5800*128.5800
=0.281

Current CPI (Mar. 2024) = 128.5800.

Pharming Group Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.030 99.240 0.039
201409 0.038 99.960 0.049
201412 0.072 99.050 0.093
201503 0.071 99.750 0.092
201506 0.068 100.230 0.087
201509 0.062 100.500 0.079
201512 0.058 99.730 0.075
201603 0.052 100.310 0.067
201606 0.043 100.260 0.055
201609 0.036 100.570 0.046
201612 0.060 100.710 0.077
201703 0.063 101.440 0.080
201706 0.014 101.370 0.018
201709 0.013 102.030 0.016
201712 0.028 101.970 0.035
201803 0.055 102.470 0.069
201806 0.066 103.100 0.082
201809 0.079 103.950 0.098
201812 0.100 103.970 0.124
201903 0.110 105.370 0.134
201906 0.125 105.840 0.152
201909 0.142 106.700 0.171
201912 0.167 106.800 0.201
202003 0.183 106.850 0.220
202006 0.200 107.510 0.239
202009 0.213 107.880 0.254
202012 0.236 107.850 0.281
202103 0.242 108.870 0.286
202106 0.255 109.670 0.299
202109 0.255 110.790 0.296
202112 0.263 114.010 0.297
202203 0.272 119.460 0.293
202206 0.290 119.050 0.313
202209 0.310 126.890 0.314
202212 0.294 124.940 0.303
202303 0.284 124.720 0.293
202306 0.281 125.830 0.287
202309 0.293 127.160 0.296
202312 0.299 126.450 0.304
202403 0.281 128.580 0.281

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Pharming Group  (XAMS:PHARM) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Pharming Group's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.8265/0.17
=4.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pharming Group was 21.20. The lowest was 2.13. And the median was 8.64.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Pharming Group Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Pharming Group's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharming Group (XAMS:PHARM) Business Description

Industry
Traded in Other Exchanges
Address
Darwinweg 24, Leiden, ZH, NLD, 2333 CR
Pharming Group is engaged in the development of products for the treatment of unmet medical needs. The company focuses on developing and producing human therapeutic proteins to provide life-changing solutions to patients. Its product includes Ruconest. The revenue is generated from the United States.

Pharming Group (XAMS:PHARM) Headlines

No Headlines